GRIK2 and malignant colon neoplasm: For colon cancers, the matched status of TRMT11-GRIK2 between primary cancer samples and lymph node metastases was 78.5% (11/14Eleven lymph node metastases were exactly matched with the status of the primary colon cancer samples, while two samples of lymph node metastases were found negative for TRMT11-GRIK2 fusion.